RiteMED Amlodipine Besilate Dosage/Direction for Use

Dosage: Adults: For both hypertension and angina the usual initial dose is 5 mg amlodipine once daily which may be increased to a maximum dose of 10 mg depending on the individual patient's response.
In hypertensive patients, amlodipine has been used in combination with a thiazide diuretic, alpha blocker, beta blocker, or an angiotensin converting enzyme inhibitor. For angina, amlodipine may be used as monotherapy or in combination with other antianginal medicinal products in patients with angina that is refractory to nitrates and/or to adequate doses of beta blockers.
No dose adjustment of amlodipine is required upon concomitant administration of thiazide diuretics, beta blockers, and angiotensin-converting enzyme inhibitors.
Special populations: Older patients: Amlodipine used at similar doses in older or younger patients is equally well tolerated. Normal dose regimens are recommended in older patients, but increase of the dose should take place with care (see Precautions and Pharmacology: Pharmacokinetics under Actions).
Hepatic impairment: Dose recommendations have not been established in patients with mild to moderate hepatic impairment; therefore dose selection should be cautious and should start at the lower end of the dosing range (see Precautions and Pharmacology: Pharmacokinetics under Actions). The pharmacokinetics of amlodipine has not been studied in severe hepatic impairment. Amlodipine should be initiated at the lowest dose and titrated slowly in patients with severe hepatic impairment.
Renal impairment: Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment, therefore the normal dose is recommended. Amlodipine is not dialysable.
Paediatric population: Children and adolescents with hypertension from 6 years to 17 years of age: The recommended antihypertensive oral dose in paediatric patient ages 6-17 years is 2.5 mg once daily as a starting dose, up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in paediatric patients (see Pharmacology: Pharmacodynamics and Pharmacokinetics under Actions).
Doses of amlodipine 2.5 mg are not possible with this medicinal product.
Children under 6 years old: No data are available.
Method of administration: For oral administration.